TELLUS THERAPEUTICS, INC. SBIR Phase I Award, September 2020
A SBIR Phase I contract was awarded to Tellus Therapeutics in September, 2020 for $312,502.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like TELLUS THERAPEUTICS, INC. SBIR Phase I Award, September 2020
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.